Cargando…
Down Syndrome patients with COVID-19 pneumonia: A high-risk category for unfavourable outcome
We report two cases of Corona Virus Disease-19 (COVID-19) in patients with Down Syndrome (DS) and describe the identification, diagnosis, clinical course and management of the infection. Down Syndrome, which is caused by trisomy 21, is characterized by immune dysregulation, anatomical differences in...
Autores principales: | Vita, Serena, Di Bari, Virginia, Corpolongo, Angela, Goletti, Delia, Espinosa, Joaquin, Petracca, Sebastiano, Palmieri, Fabrizio, Nicastri, Emanuele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703224/ https://www.ncbi.nlm.nih.gov/pubmed/33271290 http://dx.doi.org/10.1016/j.ijid.2020.11.188 |
Ejemplares similares
-
Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy
por: Musso, Maria, et al.
Publicado: (2021) -
Prolonged and severe SARS-CoV-2 infection in patients under B-cell-depleting drug successfully treated: A tailored approach
por: D’Abramo, Alessandra, et al.
Publicado: (2021) -
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
por: Cantini, Fabrizio, et al.
Publicado: (2020) -
Monoclonal Antibodies for Pre- and Postexposure Prophylaxis of COVID-19: Review of the Literature
por: Vita, Serena, et al.
Publicado: (2022) -
Baricitinib Therapy in Covid-19 Pneumonia — An Unmet Need Fulfilled
por: Goletti, Delia, et al.
Publicado: (2021)